Elizabeth A. Griffiths

Roswell Park Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.315Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

An update on the overall epidemiology, clinical characteristics, and outcomes from the COVID-19 and Cancer Consortium (CCC19).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10565

Top 67%

0.175DataRank

Top 67%2 citations

Pankil Shah, Jeremy L. Warner, Gerald Batist, Christopher R. Friese, Elizabeth A. Griffiths +15 more

Papers

Driven by 33 papers — median percentile 31. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes

Leukemia(2022)10.1038/s41375-022-01724-9

N/A

0.926DataRank · unranked

28 citations

Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A. Sekeres, David P. Steensma, Uwe Platzbecker +44 more

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Blood Advances(2022)10.1182/bloodadvances.2022008747

N/A

0.525DataRank · unranked

11 citations

Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie +45 more

An update on the overall epidemiology, clinical characteristics, and outcomes from the COVID-19 and Cancer Consortium (CCC19).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10565

Top 67%

0.175DataRank

Top 67%2 citations

Pankil Shah, Jeremy L. Warner, Gerald Batist, Christopher R. Friese, Elizabeth A. Griffiths +15 more

Checkpoint immunotherapy is associated with preferential activation of tumor antigen–specific CD4+ T cells in MDS

Blood Neoplasia(2025)10.1016/j.bneo.2025.100106

N/A

0.165DataRank · unranked

2 citations

Pragya Srivastava, Eduardo Cortes Gomez, Junko Matsuzaki, Kunle Odunsi, Laura W. Dillon +11 more

Demographics, outcomes, and risk factors for patients (Pts) with sarcoma and COVID-19: A multi-institutional cohort analysis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11523

Top 71%

0.140DataRank

Top 71%1 citations

Matthew Ingham, Corrie Painter, Rashmi Chugh, Jonathan C. Trent, Vivek Subbiah +15 more

COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease

Translational Oncology(2023)10.1016/j.tranon.2023.101709

N/A

0.115DataRank · unranked

1 citations

Cassandra Hennessy, Benjamin French, Jeremy L. Warner, Matthew D. Tucker, Daniel Hausrath +62 more

Convalescent Plasma and Improved Survival in Patients with Hematologic Malignancies and COVID-19

medRxiv(2021)10.1101/2021.02.05.21250953

N/A

0DataRank · unranked

19 citations

Jeffrey P. Henderson, Pankil Shah, Samuel M. Rubinstein, Michael J. Joyner, Toni K. Choueiri +16 more

Prediction of Life-threatening and Disabling Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

medRxiv(2021)10.1101/2021.09.24.21263986

N/A

0DataRank · unranked

0 citations

Manu Pandey, Yael Flamand, J. Erika Haydu, Roger Belizaire, Rahul S. Vedula +15 more

Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

Blood(2022)10.1182/blood.2022015832

N/A

0DataRank · unranked

36 citations

Pierre Fenaux, Marco Gobbi, Jiřı́ Mayer, Gail J. Roboz, Jürgen Krauter +21 more

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy

Blood Advances(2022)10.1182/bloodadvances.2021006166

N/A

0DataRank · unranked

25 citations

Manu Pandey, Yael Flamand, J. Erika Haydu, Roger Belizaire, Mark G. Faber +16 more

Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac037

N/A

0DataRank · unranked

19 citations

Kyle T. Enriquez, Tianyi Sun, Elizabeth J. Klein, Maheen Z. Abidi, Shailesh Advani +52 more

Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia

Blood(2022)10.1182/blood.2022016087

N/A

0DataRank · unranked

12 citations

Gabrielle Grubbs, Pragya Srivastava, Michael J. Nemeth, Elizabeth A. Griffiths, Hana Golding +2 more

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study

Cancers(2022)10.3390/cancers14174334

N/A

0DataRank · unranked

5 citations

Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P. Shah, Sarah Croessmann +42 more

Post-acute sequelae of SARS-CoV-2 infection in patients with cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e18746

N/A

0DataRank · unranked

0 citations

David J. Pinato, Sanjay Mishra, Renée Maria Saliby, Clara Hwang, Shuchi Gulati +15 more

A phase II study of CPX-351 in younger patients < 60 years old with secondary acute myeloid leukemia: Trial in progress.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps7073

N/A

0DataRank · unranked

0 citations

Salman Fazal, Elizabeth A. Griffiths, James E. Thompson, Pamela J. Sung, Steven Daniel Green +8 more

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

The Lancet Regional Health - Americas(2023)10.1016/j.lana.2023.100445

N/A

0DataRank · unranked

39 citations

Chris Labaki, Ziad Bakouny, Chih–Yuan Hsu, Andrew Schmidt, Gilberto Lopes +39 more

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101128

N/A

0DataRank · unranked

31 citations

Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu +43 more

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101072

N/A

0DataRank · unranked

18 citations

Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M. Brunner +37 more

Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

Blood Cancer Journal(2023)10.1038/s41408-023-00910-x

N/A

0DataRank · unranked

8 citations

Mina Abdelmalek, Tara Cronin, Jeffrey Baron, Zakariya Kashour, Farhan Azad +10 more

Risk prediction for clonal cytopenia: multicenter real-world evidence

Blood(2024)10.1182/blood.2024024756

N/A

0DataRank · unranked

50 citations

Rami S. Komrokji, Najla Al‐Ali, Alexandra Regelson, Susan Geyer, Anand Patel +39 more

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Modern Pathology(2024)10.1016/j.modpat.2024.100615

N/A

0DataRank · unranked

12 citations

Savanah D. Gisriel, Amer M. Zeidan, John M. Bennett, Rafael Bejar, Jan Philipp Bewersdorf +48 more

The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study

Cancer(2024)10.1002/cncr.35247

N/A

0DataRank · unranked

3 citations

Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze, Sunny R. K. Singh +52 more

Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis

Clinical Lung Cancer(2024)10.1016/j.cllc.2024.04.003

N/A

0DataRank · unranked

3 citations

Cassandra Hennessy, Grace Wilson, Vidhyalakshmi Ramesh, Clara Hwang, Joy Awosika +27 more

Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection

The Lancet Regional Health - Americas(2025)10.1016/j.lana.2025.101038

N/A

0DataRank · unranked

0 citations

Chih–Yuan Hsu, Sanjay Mishra, Elizabeth A. Griffiths, Brahm H. Segal, Clara Hwang +30 more

Unique epigenomic signatures identify biologically significant subtypes of MDS and predict response to azacitidine

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.23.650336

N/A

0DataRank · unranked

0 citations

Miguel Torres‐Martín, Masataka Taguchi, Alice Brogi, Irene Casalin, Eleonora Ceneri +12 more

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

UNC Libraries(2025)10.17615/bna9-v350

N/A

0DataRank · unranked

0 citations

Sanjay Mishra, Karen Russell, Samuel M. Rubinstein, Blau, Sibel, Daniel Y. Reuben +39 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

Inhibition of LSD1 in MDS progenitors restores differentiation of CD141Hi conventional dendritic cells

Leukemia(2020)10.1038/s41375-020-0765-5

N/A

0DataRank · unranked

12 citations

Stephanie L. Tzetzo, Eduardo Cortes Gomez, Kevin H. Eng, Sheila Sait, Joseph Kuechle +11 more

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

COVID-19 vaccination and breakthrough infections in patients with cancer

Annals of Oncology(2021)10.1016/j.annonc.2021.12.006

N/A

0DataRank · unranked

102 citations

Chris Labaki, Chih–Yuan Hsu, Ziad Bakouny, Nino Balanchivadze, Stephanie Berg +34 more

Germline variants drive myelodysplastic syndrome in young adults

Leukemia(2021)10.1038/s41375-021-01137-0

N/A

0DataRank · unranked

66 citations

Jane E. Churpek, Tom Walsh, Sioḃán Keel, Marja Hakkarainen, Thomas Schroeder +30 more

Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia

Scientific Reports(2021)10.1038/s41598-021-94539-0

N/A

0DataRank · unranked

6 citations

Weiyin Zhou, Lisa J. McReynolds, Hormuzd A. Katki, Elizabeth A. Griffiths, Swapna Thota +23 more

Elizabeth A. Griffiths

Indexed papers

Top data-sharing exemplar

Papers